for people ages 18 years and up (full criteria)
at La Jolla, California
study started
completion around
Principal Investigator
by Claude B Sirlin, MD
Headshot of Claude B Sirlin
Claude B Sirlin



This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional liver MR and liver FibroScan® ultrasound exams. MR exams and FibroScan® ultrasound exams are common exams used to monitor NAFLD. Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use.

In this study the investigators will learn how LiverScope® measurements of the liver compare to MR.

Study participants will be asked to complete a one-time visit which includes:

  • LiverScope exam
  • MR exam
  • FibroScan exam (optional)
  • Blood draw
  • Completion of study questionnaires


NAFLD, Nonalcoholic Fatty Liver, Liver Diseases, Fatty Liver, Non-alcoholic Fatty Liver Disease, Liverscope® exam, MR exam, FibroScan® exam (optional), Blood draw, Body measurements


You can join if…

Open to people ages 18 years and up

  • Age:18 years or older
  • Known or clinically suspected NAFLD
  • Weight less than 350 lbs (safety limit of MR scanner table)
  • Able to lie on LiverScope® diagnostic table for about 15 min
  • Able to hold breath repeatedly for about 20 s during MR and LiverScope® exams
  • Willing and able to undergo all study procedures

You CAN'T join if...

  • VA patient only; not a UCSD patient
  • UCSD or Livivos study personnel
  • MR contraindication(s)
  • Potential participant states that she knows that she is pregnant, thinks she may be pregnant or states she is trying to become pregnant*
  • Known chronic liver disease other than NAFLD


  • University of California San Diego accepting new patients
    La Jolla California 92037 United States

Lead Scientist at UCSD

  • Claude B Sirlin, MD
    Professor, Radiology, Vc-health Sciences-schools. Authored (or co-authored) 441 research publications


accepting new patients
Start Date
Completion Date
University of California, San Diego
Study Type
Expecting 50 study participants
Last Updated